CD1c mDCs are abundantly present in joints of RA patients, and these synovial fluid (SF)–derived mDCs have recently been demonstrated to have an extremely strong capacity to activate autologous peripheral blood (PB)–derived CD4 T cells [11]. The gene discussed is CD1C; the disease is rheumatoid arthritis.